SHC · Sotera Health Co · Webcasts, Transcripts & Audio
$16.61
+0.31 (+1.90%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$4.74B
Shares
285.63M
Volume · Nov 13
2.65M
Avg daily vol (3M)
2.3M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Sotera Health Co Webcasts
Earnings calls, investor updates, investor days and conferences for Sotera Health Co (SHC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-12-02
Sotera Health Co (SHC) December 2, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-11-18
Sotera Health Co (SHC) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-03
Sotera Health Co (SHC) Q3 2026 Earnings Call Transcript
Positive tone
Nelson Labs growth and project mix
Sterigenics performance and pricing
2026 financial outlook
Revenue
$324.89M
▲ 4.4% YoY Diluted EPS
$0.20
▲ 17.6% YoY Gross margin
55.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-09-09
Sotera Health Co (SHC) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-08-06
Sotera Health Co (SHC) Q2 2026 Earnings Call Transcript
Confident tone
Segment performance and constant currency growth
New CEO transition and leadership
Ethylene oxide (EO) litigation
Revenue
$321.38M
▲ 9.2% YoY Diluted EPS
$0.19
▲ 533.3% YoY Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-08
Sotera Health Co (SHC) June 8, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Sotera Health Co (SHC) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-19
Sotera Health Co (SHC) May 19, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Sotera Health Co (SHC) Q1 2026 Earnings Call Transcript
Confident tone
Sterigenics segment performance
Nelson Labs softness
Georgia ethylene oxide bellwether litigation dismissals
Revenue
$280.05M
▲ 10% YoY Diluted EPS
$0.09
Gross margin
52.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Sotera Health Co (SHC) Q4 2025 Earnings Call Transcript
Confident tone
Sterigenics segment performance
Long-range plan execution and 2026 outlook
Nelson Labs
Revenue
$303.44M*
▲ 4.6% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-04
Sotera Health Co (SHC) Q3 2025 Earnings Call Transcript
Confident tone
Sterigenics performance
2025 guidance
Nelson Labs turnaround
Revenue
$311.31M
▲ 9.1% YoY Diluted EPS
$0.17
▲ 183.3% YoY Gross margin
57.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Sotera Health Co (SHC) Q2 2025 Earnings Call Transcript
Confident tone
Sterigenics growth and volume recovery
Nelson Labs margin expansion
End market normalization / destocking
Revenue
$294.34M
▲ 6.4% YoY Diluted EPS
$0.03
▲ 0% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Sotera Health Co (SHC) Q1 2025 Earnings Call Transcript
Confident tone
Segment performance and growth
Sterigenics pricing
2025 guidance and outlook
Revenue
$254.52M
▲ 2.6% YoY Diluted EPS
$-0.05
▼ 350% YoY Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Sotera Health Co (SHC) Q4 2024 Earnings Call Transcript
Positive tone
Revenue and EBITDA growth
Nordion / cobalt-60 harvest timing
Tariff exposure and risk
Revenue
$290.20M*
▼ 6.5% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Sotera Health Co (SHC) Q3 2024 Earnings Call Transcript
Positive tone
Sterigenics segment performance
Continuous glucose monitors / integrated solutions
Nelson Labs performance
Revenue
$285.47M
▲ 8.5% YoY Diluted EPS
$0.06
Gross margin
55.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
Sotera Health Co (SHC) Q2 2024 Earnings Call Transcript
Positive tone
Nordion Segment
Sterigenics Segment
Nelson Labs Segment
Revenue
$276.59M
▲ 8.3% YoY Diluted EPS
$0.03
▼ 62.5% YoY Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Sotera Health Co (SHC) Q1 2024 Earnings Call Transcript
Positive tone
Financial Results
Sterigenics Segment
Ethylene Oxide Litigation
Revenue
$248.18M
▲ 12.5% YoY Diluted EPS
$0.02
▲ 100% YoY Gross margin
51.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
Sotera Health Co (SHC) Q4 2023 Earnings Call Transcript
Positive tone
Nordion / Cobalt-60
Liquidity and leverage
Revenue and EBITDA growth
Revenue
$310.24M*
▲ 23.3% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Sotera Health Co (SHC) Q3 2023 Earnings Call Transcript
Revenue
$263.18M
▲ 5.8% YoY Diluted EPS
$-0.05
▼ 155.6% YoY Gross margin
55.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Sotera Health Co (SHC) Q2 2023 Earnings Call Transcript
Revenue
$255.28M
▼ 4.3% YoY Diluted EPS
$0.08
▼ 27.3% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Sotera Health Co (SHC) Q1 2023 Earnings Call Transcript
Revenue
$220.59M
▼ 6.8% YoY Diluted EPS
$0.01
▼ 90.9% YoY Gross margin
50.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
Sotera Health Co (SHC) Q4 2022 Earnings Call Transcript
Revenue
$251.59M*
▲ 4.3% YoY Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-02
Sotera Health Co (SHC) Q3 2022 Earnings Call Transcript
Revenue
$248.70M
▲ 10% YoY Diluted EPS
$0.09
▼ 10% YoY Gross margin
54.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Sotera Health Co (SHC) Q2 2022 Earnings Call Transcript
Revenue
$266.64M
▲ 5.8% YoY Diluted EPS
$0.11
▼ 26.7% YoY Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Sotera Health Co (SHC) Q1 2022 Earnings Call Transcript
Revenue
$236.75M
▲ 11.6% YoY Diluted EPS
$0.11
▲ 175% YoY Gross margin
54.4%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-01
Sotera Health Co (SHC) Q4 2021 Earnings Call Transcript
Revenue
$241.25M*
▲ 11.3% YoY Gross margin
55.5%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
Sotera Health Co (SHC) Q3 2021 Earnings Call Transcript
Revenue
$226.16M
▲ 13.1% YoY Diluted EPS
$0.10
Gross margin
55.5%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-12
Sotera Health Co (SHC) Q2 2021 Earnings Call Transcript
Revenue
$251.92M
▲ 18.2% YoY Diluted EPS
$0.15
▲ 400% YoY Gross margin
57.1%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-13
Sotera Health Co (SHC) Q1 2021 Earnings Call Transcript
Revenue
$212.15M
▲ 12.7% YoY Diluted EPS
$0.04
Gross margin
54.4%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-01-11
Sotera Health Co (SHC) Q4 2020 Earnings Call
Revenue
$216.84M*
Gross margin
55.6%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 webcasts
Key facts
CIK
1822479
CUSIP
83601L102
13F (30d)
256 filings
238 filers
Visit website
Investor relations